Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
V G AthyrosD P Mikhailidis

Abstract

Mediterranean diet is associated with a reduced risk for cardiovascular disease (CVD). Use of plant stanols decreases low density lipoprotein cholesterol (LDL-C) concentrations. We compared the effects of the Mediterranean diet and plant stanol esters on vascular risk factors and estimated CVD (eCVD) risk. In this prospective, randomized, placebo-controlled study, 150 mildly hypercholesterolaemic subjects were randomized to Mediterranean diet, a spread containing plant stanol esters (2 g/day) or a placebo spread. Vascular risk factors were assessed every month for 4 months and the eCVD risk was calculated using the PROspective- Cardiovascular-Munster (PROCAM), Framingham, and Reynolds risk engines. Placebo had no significant effect on risk factors or eCVD risk. Mediterranean diet gradually induced a significant reduction in total cholesterol (TC), LDL-C, triglycerides, high sensitivity C-reactive protein (hsCRP), blood pressure and eCVD risk (24-32%). The plant stanol ester spread reduced (by 1 month) TC (-14%), LDL-C (-16%), hsCRP (-17%), and estimated CVD risk (26-30%). eCVD risk reduction was sustained at 4th months when the gradual Mediterranean diet eCVD risk reduction became comparable to that of the stanol group. Plant s...Continue Reading

Citations

Aug 19, 2010·Metabolic Syndrome and Related Disorders·Theodoros ChimonasUNKNOWN Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT) Collaborative Group
Apr 19, 2012·Current Opinion in Lipidology·Dylan S MacKay, Peter J H Jones
Jun 4, 2014·Nature Reviews. Endocrinology·Vasilios G Athyros, Dimitri P Mikhailidis
Oct 21, 2014·Current Cardiovascular Risk Reports·Maria KorreStefanos N Kales
Oct 16, 2012·Diabetes & Metabolism·N AhluwaliaS Hercberg
Nov 7, 2015·Cholesterol·Susanna RosinHelena Gylling
Apr 2, 2016·Current Rheumatology Reports·Sara K Tedeschi, Karen H Costenbader
May 3, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·L Schwingshackl, G Hoffmann
Jul 17, 2014·Seizure : the Journal of the British Epilepsy Association·Niki KatsikiDevaki R Nair
May 13, 2015·Nutrition Journal·Alexandra BédardSimone Lemieux
Jul 14, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F EichelmannK Aleksandrova
Jan 5, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A M HodgeG G Giles
Dec 29, 2016·International Journal of Food Sciences and Nutrition·Harry RobberechtNina Hermans
Mar 14, 2019·The Cochrane Database of Systematic Reviews·Karen ReesSaverio Stranges
Jan 18, 2012·International Journal of Food Sciences and Nutrition·Flávia Troncon RosaJ Alfredo Martínez
Apr 30, 2014·Angiology·Efthymios GotsisAsterios Karagiannis
May 29, 2018·Current Cardiology Reports·Vanessa BianconiMatteo Pirro
Feb 15, 2021·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Christina D FilippouCostas P Tsioufis
Jun 30, 2021·Progress in Cardiovascular Diseases·Massimiliano RuscicaUNKNOWN International Lipid Expert Panel (ILEP) and International Lipid Expert Panel Experts (alphabetically)
Nov 4, 2021·Phytotherapy Research : PTR·Elyas Nattagh-EshtivaniAbed Ghavami
Mar 12, 2011·Journal of the American College of Cardiology·Christina-Maria KastoriniDemosthenes B Panagiotakos
Jun 9, 2012·Current Opinion in Cardiology

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.